Detalles de la búsqueda
1.
Phase 1 Single- and Multiple-Ascending-Dose Randomized Studies of the Safety, Pharmacokinetics, and Pharmacodynamics of AG-348, a First-in-Class Allosteric Activator of Pyruvate Kinase R, in Healthy Volunteers.
Clin Pharmacol Drug Dev
; 8(2): 246-259, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30091852
2.
Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer.
Cancer Chemother Pharmacol
; 51(4): 297-305, 2003 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-12721757
Resultados
1 -
2
de 2
1
Próxima >
>>